This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Trend Of Comparable Prescriptions Filled Adjusted For Day Fall And Flu Impacts. (Graphic: Business Wire)

Walgreens (NYSE: WAG) (Nasdaq: WAG) had December sales of $6.71 billion, a decrease of 4.0 percent from $6.99 billion for the same month in fiscal 2012.

Total front-end sales decreased 1.3 percent compared with the same month in fiscal 2012, while comparable store front-end sales decreased 2.3 percent. Customer traffic in comparable stores decreased 4.0 percent while basket size increased 1.7 percent.

Prescriptions filled at comparable stores decreased by 2.3 percent in December and were flat on a day-fall adjusted (DFA) basis. This year’s December had one additional Sunday and Monday and one fewer Thursday and Friday compared with December 2011, negatively impacting prescriptions filled in comparable stores by 2.3 percentage points. DFA prescriptions filled at comparable stores were positively impacted by 1.4 percentage points due to the higher incidence of flu in this year’s December and 0.7 percentage point due to more flu shots administered in the month.

Click here for a graph showing the trend of comparable prescriptions filled adjusted for day fall and flu impacts.

December pharmacy sales decreased 4.9 percent, while comparable store pharmacy sales decreased 8.9 percent and by a day-fall adjusted (DFA) 6.6 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 2.3 percentage points. DFA comparable store pharmacy sales were negatively impacted by 5.7 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 56.7 percent of total sales for the month.

Flu shots administered at pharmacies and clinics season-to-date were nearly 5.5 million versus approximately 5.3 million last year.

Sales in comparable stores decreased by 6.1 percent in December. Calendar day shifts negatively impacted total comparable sales by 1.3 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 3.2 percentage points.

Registrations for Walgreens Balance™ Rewards loyalty program, which launched in September, totaled nearly 49 million through December.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs